Morbid obesity. Body mass index (BMI) 40.0-44.9, adult.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18-65 years Obesity with a BMI of more than 35 with comorbidity disease or more than 40 kg / m2 Obesity with comorbidity diseases Patients with consent to participate in the study
Exclusion criteria
Exclusion criteria: Debilitating diseases, including cancer, tuberculosis, AIDS Having diseases that limit patient-physician communication, such as Alzheimer's Recorded history of mental illness (major depression or uncontrolled psychosis) Drug and alcohol abuse Severe heart disease with risk of anesthesia Severe coagulopathy Not accepting nutritional orders History of gastric surgery or antireflux surgery High-grade dysplasia in Barrett's esophagus Severe iron deficiency anemia Distal lesions of the stomach or duodenum require follow-up Patients with no consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight Loss. Timepoint: Two weeks, 1,2,6, 12 months after surgery. Method of measurement: The rate of weight loss two weeks after surgery is 4%, 1 month after 8%, 3 months after 18%, 6 months after 30%, 12 months after 40% relative to baseline weight. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of ghrelin hormone. Timepoint: Six, 12 months after surgery. Method of measurement: Pg/mL. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences